StonvexLoading…
StonvexStonvexStonvexCore line items from BLK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $24.22B | $20.41B | $17.86B | $17.87B |
Operating Income | $7.04B | $7.57B | $6.28B | $6.38B |
Net Income | $5.55B | $6.37B | $5.50B | $5.18B |
EPS (Diluted) | $35.31 | $42.01 | $36.51 | $33.97 |
Total Assets | $170.00B | $138.62B | $123.21B | Not available |
Total Liabilities | $108.46B | $89.26B | $81.97B | Not available |
Cash & Equivalents | $11.47B | $12.76B | $8.74B | $7.43B |
Free Cash Flow OCF − CapEx | $3.55B | $4.70B | $3.82B | $4.42B |
Shares Outstanding | 155.07M | 154.95M | 148.50M | 152.44M |